Amyotrophic Lateral Sclerosis Treatment Market
According to Intent Market Research, the Amyotrophic Lateral Sclerosis Treatment Market is expected to grow from USD 4.0billion in 2023 at a CAGR of 10.7% to touch USD 8.1 billion by 2030. The Amyotrophic Lateral Sclerosis Treatment Market is dominated by key players such as AbbVie Inc., Alexion Pharmaceuticals (AstraZeneca), Amylyx Pharmaceuticals, Biogen Inc., F. Hoffmann-La Roche AG, Horizon Therapeutics, Mitsubishi Tanabe Pharma Corporation, Mylan N.V. (Viatris), Novartis AG, Regeneron Pharmaceuticals, Roche Holding AG, Sanofi S.A. and Vertex Pharmaceuticals.